Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC 0338-0067-01
Published October 25, 2023 · Recall initiated: August 24, 2023
Summary
FDA records drug Class II recall D-0048-2024, published October 25, 2023 and initiated August 24, 2023. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 472 vials; Lot: Lot# MKZSU02, Exp 6/30/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.
What to do
Voluntary: Firm initiated · Letter
Get an email if DOXIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DOXIL
- Manufacturer
- Baxter Healthcare Corporation
- Distributor
- Nationwide in the USA
- Lot
- Lot# MKZSU02, Exp 6/30/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only,October 25, 2023
- FDABetaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech Inc., Newtown, PA 18940, Made inOctober 25, 2023
- FDATheraBreath for Kids! Oral Rinse, sodium fluoride 0.05% (0.02% w/v fluoride ion), 16 fl. oz. 473 mL bottles,October 25, 2023
- FDABevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine PharmaceuticalsOctober 25, 2023
- FDACertain Over-The-Counter (OTC) drug products sold by Family Dollar retail stores.October 25, 2023
- FDAVancomycin 1 MG/0.1 ML Solution for Intraocular Injection, 0.8 ML Single Dose Vial, Rx only, Compounded by:October 25, 2023
Questions about this recall
Was Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC 0338-0067-01 recalled?
Yes. FDA published recall D-0048-2024 on October 25, 2023. Reported hazard: CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DOXIL.